Press

Press Releases
Azellon in the press

Press Releases

30th September 2009
Angel Biotechnology plc and Azellon Ltd today announced a collaboration to develop and GMP manufacture Azellon’s patented adult stem cell therapy for meniscal tears.
Click here for the full press release.

20th April 2009
Azellon today announced the successful seed funding of £1.6 million to develop a unique meniscal repair technology.
Click here for the full press release.

HOME ο THE COMPANY ο TECHNOLOGY ο PARTNERING AND LICENSING ο INVESTORS ο PRESS ο CONTACT ο SITE MAP ο PRINT THIS PAGE ο LOG-IN

Registered Address: University of Bristol, Department of Cellular and Molecular Medicine, School of Medical Science, University Walk, Clifton, Bristol, BS8 1TD, United Kingdom

Press

Press Releases

30th September 2009 Angel Biotechnology plc and Azellon Ltd today announced a collaboration to develop and GMP manufacture Azellon’s patented adult stem cell therapy for meniscal tears. Click here for the full press release.

20th April 2009 Azellon today announced the successful seed funding of £1.6 million to develop a unique meniscal repair technology. Click here for the full press release.

30th September 2009
Angel Biotechnology plc and Azellon Ltd today announced a collaboration to develop and GMP manufacture Azellon’s patented adult stem cell therapy for meniscal tears.
Click here for the full press release.

20th April 2009
Azellon today announced the successful seed funding of £1.6 million to develop a unique meniscal repair technology.
Click here for the full press release.